{ "cik": 1374690, "cik_padded": "0001374690", "entityName": "Larimar Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001193125-26-115878", "filed": "2026-03-19", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 91000.0, "cash": 85412000.0, "free_cash_flow": -113292000.0, "net_income": -165673000.0, "operating_cash_flow": -113201000.0, "operating_income": -172497000.0, "stockholders_equity": 78085000.0, "total_assets": 145842000.0, "total_liabilities": 67757000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8677338797464301, "roa_avg2y": -0.9574619943536945, "roa_period_end": -1.1359759191453764, "roe_avg2y": -1.32593028327671, "roe_period_end": -2.121700710763911 } }, { "accn": "0001193125-26-115878", "filed": "2026-03-19", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 515000.0, "cash": 33218000.0, "eps_diluted": -1.32, "free_cash_flow": -71275000.0, "net_income": -80604000.0, "operating_cash_flow": -70760000.0, "operating_income": -90890000.0, "stockholders_equity": 171812000.0, "total_assets": 200225000.0, "total_liabilities": 28413000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.165372616580914, "roa_avg2y": -0.5443273905996758, "roa_period_end": -0.4025671119990012, "roe_avg2y": -0.6358487291545052, "roe_period_end": -0.4691406886596978 } }, { "accn": "0001193125-26-115878", "filed": "2026-03-19", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 164000.0, "cash": 26749000.0, "eps_diluted": -0.84, "free_cash_flow": -33623000.0, "net_income": -36949000.0, "operating_cash_flow": -33459000.0, "operating_income": -41758000.0, "stockholders_equity": 81720000.0, "total_assets": 95935000.0, "total_liabilities": 14215000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.17394762604013705, "roa_avg2y": -0.3323648466312854, "roa_period_end": -0.3851461927346641, "roe_avg2y": -0.3836405829002767, "roe_period_end": -0.4521414586392559 } }, { "accn": "0000950170-25-043925", "filed": "2025-03-24", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 100000.0, "cash": 26825000.0, "eps_diluted": -1.37, "free_cash_flow": -27669000.0, "net_income": -35355000.0, "operating_cash_flow": -27569000.0, "operating_income": -36526000.0, "stockholders_equity": 110903000.0, "total_assets": 126405000.0, "total_liabilities": 15502000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.13977980757959657, "roa_avg2y": -0.34480572676913473, "roa_period_end": -0.27969621454847515, "roe_avg2y": -0.40332884619772297, "roe_period_end": -0.31879209759880256 } }, { "accn": "0000950170-24-031529", "filed": "2024-03-14", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 333000.0, "cash": 70097000.0, "eps_diluted": -2.95, "free_cash_flow": -42438000.0, "net_income": -50636000.0, "operating_cash_flow": -42105000.0, "operating_income": -50465000.0, "stockholders_equity": 64413000.0, "total_assets": 78667000.0, "total_liabilities": 14254000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.22129073323707948, "roa_avg2y": -0.5523334769542904, "roa_period_end": -0.6436752386642429, "roe_avg2y": -0.6571623243892152, "roe_period_end": -0.7861146041948054 } }, { "accn": "0000950170-23-007855", "filed": "2023-03-14", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 62000.0, "cash": 68148000.0, "eps_diluted": -3.57, "free_cash_flow": -42261000.0, "net_income": -42482000.0, "operating_cash_flow": -42199000.0, "operating_income": -42804000.0, "stockholders_equity": 89692000.0, "total_assets": 104686000.0, "total_liabilities": 14994000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.167172100075815, "roa_avg2y": -0.7731942813981636, "roa_period_end": -0.40580402346063466, "roe_avg2y": -0.9546731387222185, "roe_period_end": -0.47364313428176424 } }, { "accn": "0000950170-22-004637", "filed": "2022-03-25", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 83000.0, "cash": 1009000.0, "free_cash_flow": -22782000.0, "net_income": -23132000.0, "operating_cash_flow": -22699000.0, "operating_income": -23214000.0, "stockholders_equity": -694000.0, "total_assets": 5201000.0, "total_liabilities": 5895000.0 }, "period_end": "2019-12-31", "ratio_units": { "roa_avg2y": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.3643896253239133, "roe_avg2y": -20.83963963963964 } }, { "accn": "0001564590-21-011003", "filed": "2021-03-04", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 108000.0, "cash": 49331000.0, "free_cash_flow": -51595000.0, "net_income": -61368000.0, "operating_cash_flow": -51487000.0, "operating_income": -61122000.0, "stockholders_equity": 2914000.0, "total_assets": 121762000.0, "total_liabilities": 28491000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 9.777282086479067, "roa_avg2y": -0.54004012812841, "roa_period_end": -0.5039996057883412, "roe_avg2y": -1.5128126117020622 } }, { "accn": "0001564590-20-008984", "filed": "2020-03-05", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 55000.0, "cash": 40777000.0, "free_cash_flow": -43839000.0, "net_income": -52028000.0, "operating_cash_flow": -43784000.0, "operating_income": -52999000.0, "stockholders_equity": 78217000.0, "total_assets": 105510000.0, "total_liabilities": 27293000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3489394888579209, "roa_avg2y": -0.4388123020608862, "roa_period_end": -0.4931096578523363, "roe_avg2y": -0.5204257192013764, "roe_period_end": -0.6651750898142348 } }, { "accn": "0001564590-20-008984", "filed": "2020-03-05", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 660000.0, "cash": 32352000.0, "free_cash_flow": -52635000.0, "net_income": -57878000.0, "operating_cash_flow": -51975000.0, "operating_income": -58225000.0, "stockholders_equity": 121727000.0, "total_assets": 131621000.0, "total_liabilities": 9894000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08128024185267033, "roa_period_end": -0.4397322615692025, "roe_period_end": -0.4754738061399689 } } ], "latest_filing": { "accn": "0001193125-26-115878", "filed": "2026-03-19", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001374690.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001374690.json" }, "ticker": "LRMR" }